Stock 4547 KISSEI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kissei Pharmaceutical Co., Ltd.

Equities

4547

JP3240600001

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-25 am EDT 		5-day change 1st Jan Change
3,535 JPY -1.12% Intraday chart for Kissei Pharmaceutical Co., Ltd. +1.73% +14.40%
Mar. 20 Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program MT
Mar. 19 Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023. CI

Business Summary

KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.

Number of employees: 1,359

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceuticals
83.3 %
54,147 82.8 % 56,243 83.3 % +3.87%
Information Service
12.3 %
7,742 11.8 % 8,285 12.3 % +7.01%
Construction Contract
3.5 %
2,948 4.5 % 2,343 3.5 % -20.52%
Goods
0.9 %
543 0.8 % 621 0.9 % +14.36%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
100.0 %
65,381 100.0 % 67,493 100.0 % +3.23%

Managers

Managers TitleAgeSince
Mutsuo Kanzawa CEO
 Chief Executive Officer 74 76-03-31
Takahide Kitahara DFI
 Director of Finance/CFO 62 86-03-31
Yasuo Takehana PSD
 President 63 84-03-31
Shinji Kikuchi CTO
 Chief Tech/Sci/R&D Officer 62 88-03-31
Suminori Sagara BRD
 Director/Board Member 65 82-03-31
Eiichi Matsushita BRD
 Director/Board Member 65 83-03-31
Tetsu Takayama BRD
 Director/Board Member 62 85-03-31
Keiji Fukushima BRD
 Director/Board Member 68 79-03-31
Yoshio Furihata BRD
 Director/Board Member 62 84-03-31
Masaki Morozumi BRD
 Director/Board Member 68 80-03-31

Members of the board

Members of the board TitleAgeSince
Mutsuo Kanzawa CEO
 Chief Executive Officer 74 76-03-31
Masaki Morozumi BRD
 Director/Board Member 68 80-03-31
Shigetaka Shimizu BRD
 Director/Board Member 74 14-05-31
Masayuki Isaji AUD
 Comptroller/Controller/Auditor 69 80-03-31
Keiji Fukushima BRD
 Director/Board Member 68 79-03-31
Yasuo Takehana PSD
 President 63 84-03-31
Tetsu Takayama BRD
 Director/Board Member 62 85-03-31
Sayuri Uchikawa BRD
 Director/Board Member 73 20-05-31
Eiichi Matsushita BRD
 Director/Board Member 65 83-03-31
Minoru Nomura BRD
 Director/Board Member 77 16-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 49,311,185 32,265,747 ( 65.43 %) 4,859,912 ( 9.856 %) 65.43 %

Shareholders

NameEquities%Valuation
KISSEI PHARMACEUTICAL CO., LTD.
10.35 %
5,105,798 10.35 % 119 M ¥
DAI-ICHI LIFE HOLDINGS, INC.
4.543 %
2,240,000 4.543 % 52 M ¥
THE HACHIJUNI BANK, LTD.
4.468 %
2,203,420 4.468 % 51 M ¥
Kanzawa Co.
3.403 %
1,678,000 3.403 % 39 M ¥
Mutsuo Kanzawa
3.127 %
1,542,000 3.127 % 36 M ¥
Kissei Group Employee Stock Ownership Plan
2.612 %
1,288,000 2.612 % 30 M ¥
Nabelin Co., Ltd.
2.478 %
1,222,000 2.478 % 29 M ¥
SHIONOGI & CO., LTD.
1.854 %
914,000 1.854 % 21 M ¥
DAIICHI SANKYO CO., LTD.
1.852 %
913,000 1.852 % 21 M ¥
ONO PHARMACEUTICAL CO., LTD.
1.716 %
846,285 1.716 % 20 M ¥

Holdings

NameEquities%Valuation
CG ONCOLOGY, INC.
5.33%
 3,543,533 5.33% 155,561,099 $
ALTEOGEN INC.
1.81%
 957,590 1.81% 140,410,972 $
KISSEI PHARMACEUTICAL CO., LTD.
10.35%
 5,105,798 10.35% 119,257,298 $
SHIONOGI & CO., LTD.
0.36%
 1,077,000 0.36% 55,150,488 $
DAIICHI SANKYO CO., LTD.
0.09%
 1,734,000 0.09% 54,731,369 $
ONO PHARMACEUTICAL CO., LTD.
0.57%
 2,860,000 0.57% 46,383,223 $
JCR PHARMACEUTICALS CO., LTD.
3.79%
 4,918,000 3.79% 27,913,437 $
THE HACHIJUNI BANK, LTD.
0.64%
 3,276,402 0.64% 22,514,517 $
MIZUHO LEASING COMPANY, LIMITED
0.82%
 2,000,000 0.82% 15,355,640 $
SUZUKEN CO., LTD.
0.59%
 461,560 0.59% 14,147,654 $

Company contact information

Kissei Pharmaceutical Co., Ltd.

19-48 Yoshino

399-8710, Matsumoto

+

http://www.kissei.co.jp
address Kissei Pharmaceutical Co., Ltd.(4547)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Ratings for Kissei Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3,575 JPY
Average target price
3,833 JPY
Spread / Average Target
+7.23%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
KISSEI PHARMACEUTICAL CO., LTD. Stock Kissei Pharmaceutical Co., Ltd.
+14.40% 1.02B
MERCK KGAA Stock Merck KGaA
+4.41% 70.78B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+10.72% 9.15B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-15.34% 4.84B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+34.54% 4.22B
YUHAN CORPORATION Stock Yuhan Corporation
+5.09% 3.92B
INDIVIOR PLC Stock Indivior PLC
+23.21% 2.55B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.33% 2.24B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-24.15% 2.26B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+6.23% 1.92B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4547 Stock
  4. Company Kissei Pharmaceutical Co., Ltd.